Concepedia

Publication | Open Access

Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance

28

Citations

21

References

2022

Year

Abstract

GPX4 could serve as a novel therapeutic target for EGFR-TKI resistance in LUAD.

References

YearCitations

Page 1